A study suggests a possible link between GLP-1 usage and improved fertility.
As Super Bowl Sunday approaches, the battle off the field for advertisers to win over 120 million-plus viewers will be just as heated as the rivalry between the New England Patriots and Seattle Seahawks.
The first and only oral GLP-1 for weight loss in adults is now available to consumers.
The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.
Okava Pharmaceuticals, a San Francisco-based company, is looking to slim down household pets with a new GLP-1 implant clinical weight loss study for cats called MEOW-1.
The cash price for popular weight-loss medication Wegovy is dropping by 30% in the U.S. on Monday, according to Novo Nordisk.